Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Breast Cancer. 2020 Nov 27;28(2):496–505. doi: 10.1007/s12282-020-01189-7

Figure 1. pEZH2 T367 is differentially expressed in the nucleus and/or the cytoplasm of metaplastic carcinoma histopathological subtypes.

Figure 1.

a. Representative images of metaplastic carcinomas including squamous subtype with cytoplasmic pEZH2 T367, mesenchymal subtype with chondroid differentiation and nuclear expression of pEZH2 T367, and spindle subtype with low nuclear and cytoplasmic pEZH2 T367. b. The bar graphs show quantification of the immunostaining results of 35 metaplastic carcinomas, revealing statistically significant differences in pEZH2 T367 subcellular localization according to the histological subtype.